Oral Salbutamol 2 mg Tablet Dosing Frequency
For adults, oral salbutamol 2 mg tablets should be taken 3 to 4 times daily, though this formulation is rarely used in modern practice as inhaled formulations are strongly preferred for asthma and bronchospasm management.
Standard Oral Dosing
The typical adult dosing regimen for oral salbutamol is:
- Frequency: 3 to 4 times daily 1
- Individual dose: 2 mg per administration 1
- Total daily dose range: 6-8 mg daily when using 2 mg tablets
For controlled-release formulations (which differ from standard 2 mg tablets), the dosing is 8 mg twice daily, providing smoother plasma levels over 12-hour intervals 2, 3.
Important Clinical Context
Why Oral Salbutamol Is Not Preferred
Inhaled salbutamol is significantly superior to oral administration for treating bronchospasm and asthma. The bronchodilator response is markedly greater with inhaled formulations compared to oral tablets 4. Current asthma guidelines universally recommend inhaled short-acting beta-agonists (SABAs) as the primary route of administration 5, 6, 5.
Inhaled vs. Oral Comparison
- Inhaled salbutamol provides faster onset of action and superior bronchodilation 4
- Oral formulations have delayed onset (peak plasma levels at 240-300 minutes for controlled-release) 3
- Inhaled delivery targets the airways directly with lower systemic exposure 5, 6
- Metered-dose inhalers with spacers are as effective as nebulizers when used correctly 6, 5
Pediatric Considerations
For children weighing ≥15 kg requiring nebulized salbutamol (not oral tablets), the standard dose is 2.5 mg administered 3 to 4 times daily 1. However, oral tablets are generally not the preferred formulation in pediatric populations, where inhaled delivery via MDI with spacer or nebulization is standard 5, 7.
Safety Profile
Oral salbutamol at standard doses is generally well-tolerated, though systemic side effects (tremor, tachycardia, palpitations) may be more pronounced than with inhaled formulations 8, 2. The controlled-release formulations showed acceptable side effect profiles with twice-daily dosing 2, 3.
Clinical Pitfalls
- Do not confuse standard oral tablets with controlled-release formulations, which have different dosing schedules 2, 3
- Increasing use of any SABA formulation (>2 days/week for symptom relief) indicates inadequate asthma control and necessitates stepping up controller therapy 9
- Oral salbutamol should not be used as monotherapy for persistent asthma; inhaled corticosteroids are the preferred long-term controller medication 8, 9